Intuitive Surgical (NASDAQ:ISRG)‘s stock had its “overweight” rating restated by research analysts at Wells Fargo & Co in a report released on Monday, The Fly reports. They currently have a $655.00 target price on the medical equipment provider’s stock, up from their previous target price of $620.00. Wells Fargo & Co‘s price objective suggests a potential upside of 13.95% from the company’s previous close.

ISRG has been the subject of several other research reports. Oppenheimer initiated coverage on shares of Intuitive Surgical in a research report on Wednesday, November 20th. They set a “market perform” rating for the company. Morgan Stanley set a $620.00 price objective on shares of Intuitive Surgical and gave the company a “buy” rating in a research report on Friday, October 18th. Redburn Partners initiated coverage on shares of Intuitive Surgical in a research report on Friday, September 13th. They set a “buy” rating for the company. Piper Jaffray Companies set a $633.00 price objective on shares of Intuitive Surgical and gave the company a “buy” rating in a research report on Friday, October 18th. Finally, UBS Group raised their price objective on shares of Intuitive Surgical from $560.00 to $590.00 and gave the company a “neutral” rating in a research report on Friday, October 18th. Two equities research analysts have rated the stock with a sell rating, four have assigned a hold rating and twelve have given a buy rating to the company. Intuitive Surgical presently has a consensus rating of “Buy” and a consensus target price of $590.31.

NASDAQ:ISRG opened at $574.79 on Monday. Intuitive Surgical has a twelve month low of $430.24 and a twelve month high of $594.16. The company has a 50-day moving average of $567.38 and a 200-day moving average of $528.19. The firm has a market cap of $66.24 billion, a price-to-earnings ratio of 60.57, a price-to-earnings-growth ratio of 4.43 and a beta of 1.13.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $3.43 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $2.99 by $0.44. Intuitive Surgical had a net margin of 30.94% and a return on equity of 18.26%. The company had revenue of $1.13 billion during the quarter, compared to analyst estimates of $1.06 billion. During the same quarter last year, the firm posted $2.83 EPS. The business’s revenue for the quarter was up 22.5% on a year-over-year basis. As a group, equities analysts forecast that Intuitive Surgical will post 10.98 earnings per share for the current year.

In other Intuitive Surgical news, CFO Marshall Mohr sold 7,500 shares of the firm’s stock in a transaction dated Monday, October 28th. The shares were sold at an average price of $548.43, for a total value of $4,113,225.00. Following the completion of the transaction, the chief financial officer now directly owns 20,135 shares in the company, valued at $11,042,638.05. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, SVP Jamie Samath sold 1,021 shares of the firm’s stock in a transaction dated Tuesday, October 22nd. The stock was sold at an average price of $557.15, for a total transaction of $568,850.15. Following the completion of the transaction, the senior vice president now owns 446 shares of the company’s stock, valued at $248,488.90. The disclosure for this sale can be found here. Over the last quarter, insiders sold 25,319 shares of company stock valued at $14,351,365. Corporate insiders own 1.70% of the company’s stock.

Institutional investors and hedge funds have recently made changes to their positions in the business. Vanguard Group Inc. boosted its holdings in shares of Intuitive Surgical by 2.0% during the second quarter. Vanguard Group Inc. now owns 8,826,059 shares of the medical equipment provider’s stock worth $4,629,709,000 after purchasing an additional 169,521 shares during the period. Morgan Stanley boosted its holdings in shares of Intuitive Surgical by 39.1% during the second quarter. Morgan Stanley now owns 4,288,986 shares of the medical equipment provider’s stock worth $2,249,785,000 after purchasing an additional 1,204,750 shares during the period. Bank of New York Mellon Corp boosted its holdings in shares of Intuitive Surgical by 2.6% during the second quarter. Bank of New York Mellon Corp now owns 2,768,213 shares of the medical equipment provider’s stock worth $1,452,065,000 after purchasing an additional 68,868 shares during the period. Edgewood Management LLC boosted its holdings in shares of Intuitive Surgical by 1.1% during the second quarter. Edgewood Management LLC now owns 2,453,310 shares of the medical equipment provider’s stock worth $1,286,884,000 after purchasing an additional 26,298 shares during the period. Finally, Janus Henderson Group PLC boosted its holdings in shares of Intuitive Surgical by 6.2% during the second quarter. Janus Henderson Group PLC now owns 1,896,235 shares of the medical equipment provider’s stock worth $994,664,000 after purchasing an additional 110,885 shares during the period. Institutional investors own 85.58% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Its da Vinci Surgical System transforms the surgeon's natural hand movements outside the body into corresponding micro-movements inside the patient's body. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D vision systems, da Vinci skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures.

Featured Article: Insider Trading

The Fly

Analyst Recommendations for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.